Medical Device Researchers Slanted Trials

Researchers with financial ties to a company that makes a popular back surgery product overlooked the product’s adverse side effects.

By | July 1, 2011

Spinal fusion X-rayKRAWIEC VIA FLICKR

In a series of papers appearing this week in Spine, several experts publicly chastised other researchers for publishing misleading and biased trials on a spinal fusion product called Infuse, which surgeons can use to fuse vertebrae in the back to eliminate pain. During 13 clinical trials of Infuse that tested a total of 780 patients in the late 1990s and early 2000s,more than 20 researchers failed to report adverse side effects, and played up the advantages of Infuse over the traditional bone graft. According to the Spine papers, the researchers had received $60 to $70 million from Medtronic, Inc., the product’s maker, and many of the researchers did not disclose their financial agreements, The Chronicle reports.

Though Infuse had already been approved by the US Food and Drug Administration in 2002 for use in elderly patients whose hip bone cannot be harvested for a bone graft, the trials by researchers on Medtronic’s payroll touted the benefits of using it in a much wider population, and it is now used in a quarter of all spinal fusions, Time reports. Now, researchers are arguing the product shouldn’t be used except in a narrow patient population, pointing to studies performed by unaffiliated scientists that documented side effects including inflammation, male sterility, and unwanted bone growth.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Bizecologyd

Anonymous

July 1, 2011

Why does this stupid disqus crap cover the story I want to read?

Avatar of: rob

Anonymous

July 1, 2011

^ because you don't use Firefox with Adblock.

Avatar of: Bizecology

Anonymous

July 1, 2011

I was accessing it from a tablet computer.  Apparently this site doesn't respond to that type of computer.

Avatar of:

Posts: 0

July 1, 2011

Why does this stupid disqus crap cover the story I want to read?

Avatar of:

Posts: 0

July 1, 2011

^ because you don't use Firefox with Adblock.

Avatar of:

Posts: 0

July 1, 2011

I was accessing it from a tablet computer.  Apparently this site doesn't respond to that type of computer.

Avatar of:

Posts: 0

July 1, 2011

Why does this stupid disqus crap cover the story I want to read?

Avatar of:

Posts: 0

July 1, 2011

^ because you don't use Firefox with Adblock.

Avatar of:

Posts: 0

July 1, 2011

I was accessing it from a tablet computer.  Apparently this site doesn't respond to that type of computer.

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech